Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome

European Journal of Ophthalmology

Volumn 16, Issue 3, 2006, Pages 481-483

  Karacorlu, Murat ^a   Arf Karacorlu, S ^a   Ozdemir, H ^a  

^a Istanbul Retina Institute Inc   (Turkey)

Author keywords

Intravitreal triamcinolone acetonide; Vogt Koyanagi Harada syndrome

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG USE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA DETACHMENT; TREATMENT OUTCOME; VISUAL ACUITY; VOGT KOYANAGI SYNDROME;

EID: 33745876841     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210601600322     Document Type: Article

References (5)

1. Tesavibul N. Vogt-Koyanagi-Harada syndrome. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. Philadelphia: W.B. Saunders; 2002: 748-56.
2. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003; 121: 57-61.
3. Danis RP, Ciulla TA, Pratt LM, Ankliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000; 20: 244-50.
4. Andrade RE, Muccioli C, Farah ME, Nussenblatt RB, Belfort R. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 2004; 137: 572-4.
5. Jonas JB. Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia. Am J Ophthalmol 2004; 137: 367-8.